《缺血性二尖瓣反流》_第1頁(yè)
《缺血性二尖瓣反流》_第2頁(yè)
《缺血性二尖瓣反流》_第3頁(yè)
《缺血性二尖瓣反流》_第4頁(yè)
《缺血性二尖瓣反流》_第5頁(yè)
已閱讀5頁(yè),還剩30頁(yè)未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

ISCHEMICMITRALREGURGITATIONINPATIENTSWITHACUTEMYOCARDIALINFARCTION急性心肌梗死合并缺血性二尖瓣反流編輯pptMechanicalComplicationsof

AcuteMyocardialInfarctionPrimaryPCIastheprincipalreperfusionstrategyfollowingSTEMI,theincidenceofmechanicalcomplicationshasreducedsignificantlytolessthan1%Ruptureoftheleftventricularfreewall(0.52%)Papillarymuscle(0.26%)Ventricularseptum(0.17%)編輯pptSurvivalafterMechanicalcomplication編輯pptACUTEMITRALREGURGITATION(MR)MildtomoderatechronicMRisfoundin15%to45%ofpatientsafterAMI,usuallytransientandasymptomaticAcuteMRsecondarytopapillarymuscleruptureisalife-threateningcomplicationwithapoorprognosisOccursin0.25%ofpatientsfollowingAMIandrepresentsupto7%ofpatientsincardiogenicshockfollowingAMIDiagnosedbetween2to7daysafterAMI,themediantimetopapillarymuscleruptureisapproximately13hoursIntroduction編輯pptFollowingAMI,incombinationwithchangesinLVshapeandregionalwallfunction,resultsinacuteMREvenslightmodificationsofLVgeometrycausedbyregionalwall-motionabnormalitymaycontributetotheincreasedfrequencyofMRafterAMICommonlyfollowinganinferiorMI,owingtothesinglebloodsupplytotheposteromedialpapillarymusclefromthePDPathophysiology編輯pptPrevalenceofmitralregurgitation(MR)withrespecttoposteriorpapillarymuscle(PM)perfusionpatternandinferiormyocardialinfarction(MI).PaoloVocietal.Circulation.1995;91:1714-1718Copyright?AmericanHeartAssociation,Inc.Allrightsreserved.編輯pptImmediatepulmonaryedema,hypotension,and,insomecases,cardiogenicshockAnewpansystolicmurmurisheardloudestatthecardiacapexElectrocardiographyusuallyconfirmsaninferiororposteriorMIChestradiographydemonstratespulmonaryedema,whichoccasionallyislocalizedtotherightupperlobeDiagnosis編輯pptDiagnosis編輯pptPromptdiagnosiswithimmediateinitiationofaggressivemedicaltherapyisvitaluntilemergentsurgicalinterventioncanbeperformedConcomitantrevascularizationduringmitralvalvesurgeryisassociatedwithimprovedshort-termandlong-termoutcomesTreatment編輯pptConcomitantrevascularizationduringmitralvalvesurgeryisassociatedwithimprovedshort-termandlong-termoutcomes

Kaplan-Meiergraphsdemonstrating(A)perioperativeand(B)15-yearactuarialsurvivalbenefitinpatientsundergoingconcomitantcoronaryrevascularizationfollowingacutepostinfarctionmitralregurgitation.([A]FromChevalierP,BurriH,FahratF,etal.Perioperativeoutcomeandlong-termsurvivalofsurgeryforacutepost-infarctionmitralregurgitation.EurJCardiothoracSurg2004;26(2):332;and[B]AdaptedfromLorussoR,GelsominoS,DeCiccoG,etal.Mitralvalvesurgeryinemergencyforsevereacuteregurgitation:analysisofpostoperativeresultsfromamulticentrestudy.EurJCardiothoracSurg2008;33(4):577,withpermission.)編輯pptTreatmentwithMRMedicaltherapyAimstoreducetheafterload,witharesultantdecreasedregurgitantfractionandincreasedforwardstrokevolumeandcardiacoutputVasodilatorsandinodilators,suchasnitrites,sodiumnitroprusside,diuretics,andphosphodiesterase-3inhibitors編輯pptmechanicalcardiacsupportIABPImpellaRecoverdeviceECMOcircuit,VADPositive-pressureventilationisusedwithgreateffect編輯pptAcutepostinfarctionMRisassociatedwithaninhospitalmortalityofbetween70%and80%withmedicaltreatment編輯pptEmergentsurgeryremainsthecornerstoneoftreatment編輯ppt編輯pptThelargestseriesofpatientswhounderwentsurgicalinterventionforpapillarymusclerupture:fromApril1985toJune2002werereviewed,55consecutivepatientswereincludedPatientswithacuteMR(definedasoccurringwithin1monthoftheinfarction)編輯pptThemeandelaybetweenAMIandmitralvalvesurgerywas7.3±7.4days(range1–33days)Surgerytookplacewithin:thefirst24hofdiagnosisofMRin24patientsBetweenthesecondandthefourteenthdayin27casesAfterthesecondweekin4cases編輯pptKaplan-Meiergraphshowingperioperative(thirty-day)survivalaccordingtorevascularisationstatus.PhilippeChevalieretal.EurJCardiothoracSurg2004;26:330-335?2004byOxfordUniversityPressPerioperativemortalitywas24%NodifferenceinearlymortalitybetweenpatientsundergoingconcomitantCABGandNorevascularizedgroup(CABG27.3%vsnoCABG26.4%;P>.9)編輯pptKaplan-Meiergraphshowinglong-termmortalityofpatientswhosurvivedtheperioperativeperiod.PhilippeChevalieretal.EurJCardiothoracSurg2004;26:330-335?2004byOxfordUniversityPresslong-termsurvivalimprovedinpatientsundergoingconcomitantrevascularizationat15years(CABG64%vsnoCABG23%;P<.001)編輯pptPhilippeChevalieretal.EurJCardiothoracSurg2004;26:330-335OnlytheAbsenceofRevascularisationwassignificantlypredictiveofincreasedperioperativemortalityFactorspredictiveofperioperativemortality編輯pptmitralvalverepairormitralvalvereplacement?編輯ppt編輯pptBaselineandOperativeCharacteristicsofPatientsWhoUnderwentSurgeryforPMR編輯pptPreoperativeangiography,performedinallpatientsexcept1single-vesselCADin17patients(31%)2-vesselCADin19patients(35%)3-vesselCADin14patients(26%)LeftmainCADin3patients(6%)編輯pptOperativemortalityaftersurgeryforpost-MIPMRstratifiedaccordingtopredictorsoflowmortality(surgeryperformedafter1990withassociatedCABG).AntonioRussoetal.Circulation.2008;118:1528-1534Copyright?AmericanHeartAssociation,Inc.Allrightsreserved.Improveoperativemortality(OR0.18;95%CI0.04–0.83;P=.011).編輯pptOverall(includingoperativemortality)long-termsurvival(solidline)andlong-termsurvivalfreeofCHF(dashedline)aftersurgeryforpost-MIPMR.Thenumberswitheachcurveindicatethe5-and10-yearestimatedsurvivalandsurvivalfreeofCHF(±SE).AntonioRussoetal.Circulation.2008;118:1528-1534Copyright?AmericanHeartAssociation,Inc.Allrightsreserved.編輯pptMRepVS.MVRMRepandMVRintermsofsurvival(5-yrs,62±13%versus66±7%;P=0.48)TrendforhighersurvivalfreeofCHFwithMRep(5-yrs,62±13%versus49±8%;P=0.13)Earlyaftersurgery,9patientsmilddegreeofMR,7afterMRepand1afterMVR(P=0.01),and1patienthadsevereMRintheMRepgroupThroughoutfollow-up,6patientsdevelopedsignificantMR,4intheMRepgroupand2intheMVRgroup(P=0.021).Reoperationforanyreasonwasperformedin3patients,2patientsafterMVRand1patientafterMRep.編輯pptconcomitantCABGThetrendafterconcomitantCABGforhigheroverallsurvival(5-yearsurvival,71±7%versus42±14%;P=0.16)andforhighersurvivalfreeofCHF(5-yearsurvival,57±8%versus33±14%;P=0.18)Afterpropensity-scoreadjustmentforage,sex,EF,severityofCAD,andyearofsurgery,CABGshowedonlyaweaktrendtowardlowerlong-termmortality(adjustedrelativerisk,0.45;95%CI,0.20to1.1;P=0.077).Thepatientsoperatedonbeyondthefirstmonthdisplayednobenefitinlong-termoutcome(allP>0.5)編輯ppt

Latesurvivalinoperativesurvivorsofsurgeryforpost-MIPMR(dashedline)vspatient

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論